AdiBamnolkerDO

PubMed

• 2 citations
  Direct Oral Anticoagulants Versus Warfarin for Venous Thromboembolism Prophylaxis in Patients With Nephrotic Syndrome: A Retrospective Cohort Study.
  Aminat Tijani, Eric M Coons, Britta Mizuki, Miranda Dermady, Katerina Stanilova, Ashley L Casey, Muhannad Alqudsi, Mariella Gastanaduy, Ardem Elmayan, Adi Bamnolker, J...> ;The Annals of Pharmacotherapy. 2023 Jul 1
• 40 citations
  Timing of steroid initiation and response rates to immune checkpoint inhibitors in metastatic cancer.
  Diana Maslov, Karine Tawagi, Madhav Kc, Victoria Simenson, Helen Yuan, Cameron Parent, Adi Bamnolker, Richa Goel, Zoe Blake, Marc R. Matrana, Daniel H. Johnson> ;Journal for Immunotherapy of Cancer. 2021 Jul 1

Journal Articles

• Timing of steroid initiation and response rates to immune checkpoint inhibitors in metastatic cancer. Journal for Immunotherapy of Cancer.  
  Maslov DV, Tawagi K, Madhav KC, Simenson V, Yuan H, Parent C, Bamnolker A, Goel R, Blake Z, Matrana MR, Johnson DH., Journal for Immunotherapy of Cancer, 7/9/2021

Abstracts/Posters

• Direct Oral Anticoagulants Versus Warfarin for Venous Thromboembolism Prophylaxis in Patients with Nephrotic Syndrome: A Retrospective Cohort Study
  Stanilova K, Tijani AA, Coons EM, Casey A, Mizuki B, Dermady M, Bamnolker A, Alqudsi M, Velez JCQ, American Society of Nephrology, Abstract submitted 5/2022
• Clinical outcomes for advanced hepatocellular carcinoma patients treated with systemic agents in real-world practice.
  Tawagi K, Maslov DV, Madhav KC, Markabawi D, Mukkamala S, Farag F, Yuan H, Bamnolker A, Saeed R, Blake Z, Matrana M, & Johnson D., Journal of the National Comprehensive Cancer Network, American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium, 3/2021
• The impact of hypertension on response rates in patients with renal cell carcinoma.
  Maslov DV, Tawagi K, Madhav KC, Goel R, Yuan H, Bamnolker A, Blake Z, Song W, Johnson D, & Matrana M., Journal of Clinical Oncology, American Society of Clinical Oncology (ASCO) Genitourinary Annual Symposium, 2/2021
• IMDC scores and clinical outcomes for renal cell carcinoma patients treated with 1st line NCCN guideline directed therapy in real-world practice.
  Maslov DV, Tawagi K, Madhav KC, Goel R, Yuan H, Bamnolker A, Blake Z, Song W, Johnson D, & Matrana M., American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium, 2/2021
• Impact of body mass index on survival rates in patients receiving immune checkpoint inhibitors.
  Maslov DV, Tawagi K, Simenson V, Yuan H, Parent C, Bamnolker A, Goel R, Blake Z, Madhav KC, Matrana M, & Johnson D., Journal of Clinical Oncology, 5/2020
• Cumulative steroid doses and response rates to immune checkpoint inhibitors in metastatic cancer.
  Maslov DV, Tawagi K, Simenson V, Yuan H, Parent C, Bamnolker A, Goel R, Blake Z, Madhav KC, Matrana M, & Johnson D., Journal of Clinical Oncology, 5/2020
• Join now to see all

Lectures

• The misdiagnosis and treatment of Lipschutz ulcers as an active infectious process inducing neutropenia and delayed healing. 
  Touro University Nevada Annual Research Conference - 4/2018